A pre-clinical study to investigate the anti-diabetic potential of <i>p</i>-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats. | J Diabetes Metab Disord;22(1): 571-580, 2023 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

A pre-clinical study to investigate the anti-diabetic potential of p-propoxybenzoic acid as a multi-target inhibitor in streptozotocin-nicotinamide induced type-2 diabetic rats.

Raval, Keval Y; Tirgar, Pravin R.

Affiliation

Raval KY; School of Pharmacy, R K University, Rajkot, Gujarat India.
Tirgar PR; School of Pharmacy, R K University, Rajkot, Gujarat India.

J Diabetes Metab Disord ; 22(1): 571-580, 2023 Jun.

Article in En | MEDLINE | ID: mdl-37255789

Key words

Multi-target inhibitor; Nicotinamide; Streptozotocin; Type-2 Diabetes Mellitus; p-propoxybenzoic acid

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Diabetes Metab Disord Year: 2023 Document type: Article Country of publication: Switzerland

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Diabetes Metab Disord Year: 2023 Document type: Article Country of publication: Switzerland